Category: Musculoskeletal

Low Dye strapping is a widely used taping technique in podiatry to alleviate foot pain, particularly from conditions like plantar fasciitis. This rigid adhesive tape application supports the foot’s longitudinal arch, reduces excessive pronation, and offloads strained structures.

Origins and Technique

Low Dye Strapping

Developed by physical therapist Tom Low in the mid-20th century, Low Dye strapping targets the medial longitudinal arch to mimic ligamentous support. Clinicians apply zinc oxide or rigid sports tape in layers: starting with a figure-eight around the forefoot and heel, followed by medial and lateral strips to elevate the arch, and anchors at the metatarsals and tibia.

The process begins with skin preparation using tincture of benzoin for adhesion, then baseline strips from the plantar surface up the sides. A key lowermost strip encircles the heel and midfoot, preventing arch collapse during gait. Additional “shuttle” strips weave medially and laterally for reinforcement, typically lasting 3-7 days before reapplication.

This image shows a foot with Low Dye tape applied, highlighting the pink and blue strips stabilizing the arch and heel.

Proper technique minimizes skin irritation while maximizing biomechanical control, making it a staple in clinical settings for podiatrists treating overuse injuries.

Biomechanical Mechanism

Low Dye strapping works by limiting subtalar joint pronation, which flattens the arch and stretches the plantar fascia during weight-bearing. It acts as an external “sling,” redistributing ground reaction forces away from the heel and midfoot.

Research indicates it increases navicular height by 5-10 mm immediately post-application, reducing plantar pressure by up to 40% under the heel. This offloads the plantar fascia, Achilles tendon, and tibialis posterior, addressing pain from repetitive microtrauma.

During dynamic gait, the tape resists calcaneal eversion, promoting a more neutral foot posture. This alters kinetic chain loading, potentially easing proximal symptoms like shin splints or knee pain.

Primary Indications

Primarily indicated for plantar fasciitis, Low Dye strapping relieves heel pain from inflamed fascia insertion at the calcaneus. Patients report rapid symptom reduction, often within 48 hours, due to decreased tensile strain.

It benefits other arch-related pathologies, including posterior tibialis tendon dysfunction, where arch support counters insufficiency. Achilles tendinopathy responds as reduced pronation lessens pull on the gastro-soleal complex.

Athletes with fat pad atrophy or metatarsalgia find utility in forefoot anchoring, while golfers or runners use it prophylactically for medial overload.

Evidence from Clinical Studies

A 2005 randomized trial with 65 plantar fasciitis patients showed Low Dye taping reduced pain by 31.7 mm on a visual analog scale versus controls after 3-5 days (p<0.001). This short-term efficacy supports its diagnostic role, confirming mechanical etiology.

A 2026 meta-analysis of 11 RCTs found low-dye superior to placebo for postoperative pain (MD -1.24, 95% CI -2.39 to -0.08, p=0.04) and quality of life in plantar fasciitis, though not outperforming orthotics or sham taping long-term.

Studies affirm biomechanical changes: one measured 50% pronation reduction during stance phase, correlating with symptom relief. However, evidence quality varies, with small samples limiting generalizability.

Application Protocol

Apply to clean, dry skin after shaving hair if needed. Start supine: anchor 5cm tape at first metatarsal head, circle under foot to lateral malleolus. Repeat for heel counter.

Second layer: low dye strip from navicular, under arch to fifth metatarsal, up medial calf. Add three medial-lateral shuttles for arch lift, ending with tibial anchor. Test with toe/heel raises; trim edges.

Reapply weekly, monitoring for blisters. Combine with stretching, night splints, or orthoses for synergy.

Advantages and Limitations

Advantages include low cost (under $10 per application), non-invasiveness, and immediate effect without custom fabrication. It serves as a bridge to orthotics, aiding prognosis—if pain persists post-taping, consider alternative diagnoses like nerve entrapment.

Limitations: tape loosens with sweat (lasting 3-5 days in athletes), risks skin allergy (5-10% incidence), and lacks long-term data beyond 2 weeks. Not ideal for severe pes cavus or infection.

Compared to alternatives:

Technique	Duration	Cost	Efficacy (Pain Reduction)	Skin Risk
Low Dye Strapping	3-7 days	Low	High short-term	Moderate
Custom Orthotics	Permanent	High	High long-term	Low
Kinesio Taping	3-5 days	Low	Moderate	Low
Night Splints	Overnight	Medium	Moderate	Low

Integration in Treatment Plans

Incorporate Low Dye as first-line conservative care alongside eccentric exercises and iontophoresis. For podiatry practice, use diagnostically: 70% pain relief predicts orthotic success.

Patient education emphasizes compliance; self-application videos empower home use. Monitor progress with numeric pain scales pre/post-taping.

Future research should explore hybrid taping with elastomers for durability and RCTs versus shockwave therapy.

Potential Complications and Contraindications

Common issues: friction blisters (mitigate with Hypafix underlay), allergic dermatitis (patch test zinc oxide), or tape curl (use anchors). Remove if circulation impairs.

Contraindications: open wounds, fragile skin (diabetics stage 2+), or allergy to adhesives. Assess vascular status first.

Lisfranc fractures represent a serious midfoot injury involving disruption of the tarsometatarsal (TMT) joint complex. These injuries demand precise diagnosis and management to prevent long-term complications like chronic pain and arthritis.

Anatomy Overview

The Lisfranc joint complex spans the midfoot, linking the metatarsals (M1-M5) to the tarsals, including the medial, middle, and lateral cuneiforms plus the cuboid. Stability arises from the recessed second metatarsal base, forming a “Roman arch,” with the Lisfranc ligament anchoring the medial cuneiform to the second metatarsal base. This ligamentous and osseous architecture bears significant weight during gait, transmitting forces from the hindfoot to the forefoot.

Dorsal and plantar ligaments, along with intermetatarsal structures, reinforce the joint. The second metatarsal’s keystone position, wedged between cuneiforms, provides inherent stability, yet vulnerability persists to axial loads or twisting.

Mechanisms of Injury

High-energy trauma, such as motor vehicle accidents or falls from height, accounts for many Lisfranc fractures, often fracturing metatarsals or cuneiforms alongside dislocation. Low-energy incidents, like twisting the foot in sports (e.g., football or windsurfing), cause ligamentous sprains or subtle subluxations.

Hyperplantarflexion or direct strikes can shear the metatarsal bases, while axial loading with foot rotation disrupts the joint. In athletes, these injuries mimic ankle sprains but affect the midfoot arch. Incidence sits at about 1 in 55,000, though underdiagnosis inflates true rates.

Clinical Presentation

Patients report acute midfoot pain, swelling, and inability to bear weight, often with plantar ecchymosis across the arch—a hallmark sign from retracted dorsal vessels. Deformity may show as widened forefoot or flattened arch.

Tenderness localizes over the first or second TMT joint, worsening with pronation or passive dorsiflexion. Neuropathy can cause numbness in toes. In subtle cases, pain persists during push-off in gait, delaying recognition.

Diagnostic Imaging

Weightbearing anteroposterior (AP), lateral, and oblique radiographs reveal key signs: diastasis greater than 2 mm between the first-second metatarsal bases or “fleck” sign from avulsed Lisfranc ligament bone. Lateral views show height loss between cuneiform and metatarsal bases.journals.

Non-weightbearing films often miss instability; stress views or CT scans confirm subtle dislocations, detailing fractures and alignment. MRI excels at ligament tears, guiding surgical decisions in equivocal cases.

Classification Systems

The Hardcastle-Myles system categorizes by anatomy: Type A (total dislocation), Type B (partial, divergent or convergent), Type C (divergent with instability). Myerson refines B and C subtypes. These aid prognosis; purely ligamentous injuries fare worse than bony ones.

Quenu and Kuss predated these, but modern schemes emphasize instability over displacement

Nonoperative Management

Stable injuries without diastasis (<2 mm) or displacement suit immobilization in a non-weightbearing cast or boot for 6-8 weeks, followed by serial imaging. Partial weightbearing resumes if alignment holds, with physical therapy restoring strength and proprioception.

This approach fits extra-articular fractures or sprains confirmed stable on stress views. Success hinges on compliance; failure risks deformity.

Surgical Interventions

Unstable injuries demand operative fixation for anatomic reduction, the cornerstone of good outcomes. Open reduction internal fixation (ORIF) uses screws or plates across TMT joints, often after 10-14 days to reduce swelling.

Primary arthrodesis fuses irreparably damaged joints, especially second TMT, showing lower arthritis rates than ORIF in ligamentous cases. K-wires suffice temporarily but risk migration. Staged procedures—external fixation then ORIF—handle severe trauma.

Postoperative Care

Post-ORIF, non-weightbearing lasts 6-12 weeks in cast or boot, with screws often removed at 4 months. Therapy addresses stiffness, targeting gait normalization by 3-6 months. Full recovery spans 6-12 months, longer for athletes.

Complications like infection or hardware irritation occur in 10-20%; compartment syndrome demands vigilance.

Complications and Prognosis

Missed diagnoses lead to midfoot collapse, arthritis (up to 75% post-ORIF), and chronic pain. Post-traumatic osteoarthritis prompts salvage arthrodesis. Return to sport averages 4-6 months, with 40-80% full recovery depending on injury severity.

Risk factors include delay >6 weeks or nonanatomic reduction (>2 mm malalignment)

Rehabilitation Strategies

Phase 1 (0-6 weeks): Immobilization, elevation, edema control. Phase 2 (6-12 weeks): Protected weightbearing, range-of-motion exercises. Phase 3 (3-6 months): Strengthening, proprioception, plyometrics. Custom orthoses support the arch long-term.​

Evidence favors early intervention; athletes benefit from sport-specific protocols.

Recent Advances

Dual plating reduces hardware failure versus screws alone. Arthroscopic-assisted reduction minimizes morbidity. Biomechanical studies validate primary arthrodesis for severe injuries, cutting reoperation rates.

Research stresses weightbearing CT for instability detection.

Leg length differences in runners are common, often small, and frequently well tolerated.

Leg Length Differences in Runners

Leg length difference, also called leg length discrepancy, refers to a mismatch in the length of the lower limbs. In runners, this issue attracts attention because running is a repetitive, single-leg loading activity with little time for compensation between foot strikes. Even so, research suggests that small discrepancies are often not problematic and may be asymptomatic in many runners. The key clinical question is not simply whether a discrepancy exists, but whether it alters mechanics enough to contribute to pain, injury, or reduced performance.

A useful distinction is between structural and functional leg length difference. Structural discrepancy means the bones are actually different lengths, while functional discrepancy comes from pelvic tilt, foot posture, joint contracture, scoliosis, or other alignment factors that create the appearance of unequal legs. In practice, runners may present with either form, and the two can overlap. This matters because the treatment approach differs: a true bony discrepancy may respond to a lift or shoe modification, whereas a functional difference may improve with addressing mobility, strength, or motor control.

Biomechanically, running magnifies asymmetry more than walking. Running involves a shorter stance phase, single-limb support, and greater vertical loading, so differences between the limbs may become more apparent under impact. Experimental work suggests that even mild induced leg-length inequality can change ground reaction forces, stride length, stance time, and joint motion during running. These changes do not automatically cause injury, but they show that the body does adapt to asymmetry, often by altering loading patterns at the hip, knee, ankle, and foot.

The clinical literature does not support a simple “more difference equals more injury” rule. A classic marathon runner study found that discrepancies of 5 to 25 mm were not necessarily a functional detriment, and lifts did not show consistent benefit. In adolescent runners, leg-length inequality was not broadly associated with running-related injury, although males with a discrepancy greater than 1.5 cm had a higher likelihood of lower-leg injury. Other reports suggest that differences up to about 1 cm are common and often tolerated, while discrepancies above 2 cm are more likely to alter biomechanics and become clinically relevant. This means that magnitude matters, but symptoms and individual response matter just as much.

From a performance perspective, the effect is also nuanced. Some studies of running economy and bone length suggest that longer tibial or lower-leg proportions may be associated with better performance in certain runners, but these findings are about limb proportions rather than pathological discrepancy. That distinction is important. A naturally long or short leg is not the same as an acquired mismatch, and athletic success can occur despite asymmetry. Elite runners may compensate effectively through stride adjustments, arm swing changes, pelvic control, and long-term neuromuscular adaptation. In other words, asymmetry does not automatically mean inefficiency.

For clinicians, the main challenge is deciding when a discrepancy is clinically meaningful. Measurement method is a major issue. Tape measures, visual inspection, and even some clinical screening methods can be inaccurate, especially for small differences, while imaging is more precise for true bony length. A runner with unilateral shin pain, recurrent iliotibial band symptoms, Achilles complaints, or pelvic asymmetry may merit closer assessment than a runner with an incidental 5 mm difference and no symptoms. The best practice is to assess the whole kinetic chain rather than treating the leg length number in isolation.

Treatment should therefore be individualised. Small discrepancies often need no intervention, particularly if the runner is pain-free and training well. If symptoms appear related, a gradual trial of a lift, heel raise, or shoe modification can be reasonable, but large immediate corrections may provoke new symptoms. For functional discrepancies, mobility work, strengthening, gait retraining, and load management may be more appropriate than adding a lift. A runner’s history, training surface, footwear, speed demands, and side dominance should all shape management.

In summary, leg length differences in runners are common and often benign. Small discrepancies are usually well tolerated, while larger differences may alter biomechanics and increase the risk of certain injuries in some individuals. The most defensible clinical approach is not to chase every minor asymmetry, but to determine whether the discrepancy is structural or functional, whether it is measurable with confidence, and whether it meaningfully contributes to symptoms or loading problems. For runners, the leg length difference itself is often less important than how the body has adapted to it.world+2

The kinetic wedge is a forefoot orthotic modification designed to facilitate first ray plantarflexion and improve hallux function during gait, especially in cases of functional hallux limitus. It is used to reduce resistance to first metatarsophalangeal joint dorsiflexion and to support a more efficient windlass mechanism.

The kinetic wedge on foot orthotics

A kinetic wedge is a specific orthotic extension first described and popularised by Howard Dananberg. Its classic design places a thicker posting under metatarsals 2 to 5, with relative accommodation beneath the first metatarsal region, allowing the first ray to plantarflex more freely as load transfers forward.

The main clinical idea is simple: if the first ray is not able to plantarflex effectively, the hallux may fail to dorsiflex normally during propulsion. That can limit the windlass mechanism, alter gait progression, and contribute to compensatory loading patterns. The kinetic wedge aims to reduce that resistance by shifting plantar pressure away from the first metatarsal head and encouraging a smoother sagittal-plane transition.

Biomechanical rationale

In normal propulsion, hallux dorsiflexion tensions the plantar fascia and helps elevate the medial longitudinal arch, while the first metatarsal plantarflexes and the rearfoot can move into a more efficient position. The kinetic wedge is intended to make that sequence easier by unloading the first metatarsal head and supporting first ray motion.

This is why it is often discussed in relation to functional hallux limitus rather than rigid structural hallux limitus. In a functional restriction, the joint may appear limited under load but move more freely when mechanical conditions are improved. The kinetic wedge is one way to change those loading conditions.

Clinical applications

The kinetic wedge is most commonly used for functional hallux limitus, sagittal plane block, and windlass mechanism dysfunction. Clinically, it may be considered when the patient shows reduced first MTPJ function during stance, limited propulsion through the medial forefoot, or symptoms thought to relate to impaired first ray mechanics.

It has also been studied as a way to reduce plantar pressure under the first metatarsophalangeal joint. One study found a significant reduction in plantar pressure beneath the first MTPJ in people with moderate to severe functional hallux limitus, although it did not produce broad changes in proximal kinematics or self-reported pain over the study period.

Evidence base

The evidence suggests the kinetic wedge can change local mechanics, but its clinical effects are less consistently impressive than the theory behind it. A 2024 study found that using a kinetic wedge reduced the force required for a hallux dorsiflexion resistance test by about 39% in asymptomatic individuals, supporting the idea that it can facilitate the windlass mechanism.

However, not all outcomes improve in a straightforward way. In the Ottawa study, there were no significant increases in trunk, hip, knee, or ankle range of motion, no significant change in centre of pressure velocity, and no significant reduction in perceived pain after two months. That suggests the wedge may influence foot mechanics more reliably than it changes whole-body gait or symptoms

Practical prescription points

In practice, the kinetic wedge is usually built into a custom orthosis or a prefabricated device rather than added as a standalone modification. Its material thickness and placement matter, because the goal is to allow the first ray to move down and through loading rather than to rigidly prop the forefoot.

It should be matched to the patient’s presentation. A person with functional hallux limitus and a pronatory compensation pattern may benefit, whereas someone with rigid first MTPJ arthritis, severe structural deformity, or another dominant pain driver may not respond well. The wedge is best viewed as a targeted mechanical aid, not a universal solution.

Limitations and controversies

The kinetic wedge has a strong biomechanical narrative, but the clinical literature is still relatively small. Some studies support improved hallux function or reduced local force, while others show limited effects on pain or global gait measures.

There is also some debate about whether improving first ray plantarflexion alone is sufficient to produce durable symptom relief. In real patients, footwear, calf flexibility, first MTPJ joint integrity, load tolerance, and activity demands all interact with orthotic design. For that reason, the kinetic wedge is often most useful when it is part of a broader treatment plan.

The kinetic wedge is a focused orthotic modification used to facilitate first ray plantarflexion and improve hallux dorsiflexion during gait. Its main value lies in functional hallux limitus and related sagittal plane dysfunction, where it can reduce pressure beneath the first metatarsal head and help restore a more efficient windlass mechanism

Overall, the kinetic wedge is a plausible and clinically useful device, but it should not be oversold. Current evidence supports changes in local mechanics more clearly than it supports large, consistent improvements in pain or whole-limb gait variables. In practice, its success depends on correct patient selection, sound orthotic design, and integration with the broader biomechanical context.

Joplin’s neuroma is a rare painful nerve condition of the foot, usually affecting the medial plantar digital proper nerve to the big toe. It is commonly associated with bunion deformity or prior bunion surgery, and it can cause burning, tingling, numbness, and focal pain along the inner side of the hallux.

Joplin’s Neuroma in the Foot

Joplin’s neuroma is an uncommon neuropathic pain syndrome involving the medial proper digital nerve of the hallux, the nerve that supplies sensation to the inner side of the big toe. It is not a true tumor in the usual sense; rather, it is a fibrotic, irritated, and painful thickening of the nerve that develops after repeated compression or injury. In clinical practice, it is much less frequently discussed than Morton’s neuroma, but it can be equally disabling for the patient because it interferes with walking, footwear tolerance, and daily activity.pure.

The condition is especially relevant in people with hallux valgus, bunion deformity, or a history of bunion surgery. These situations can alter the mechanics of the forefoot and place traction or compression on the medial digital nerve, leading to chronic irritation. Repetitive pressure from footwear, deformity-related friction, and prior surgical scarring are all thought to contribute to the nerve’s pathological changes.

Pathology

The term “neuroma” can be misleading because Joplin’s neuroma is more accurately described as a perineurial fibrosis or traumatic neuritis rather than a neoplastic growth. The nerve becomes thickened and hypersensitive after ongoing mechanical stress. This differs from the better-known Morton’s neuroma, which more often affects the intermetatarsal spaces of the forefoot, usually between the third and fourth toes. Joplin’s neuroma is located on the medial side of the great toe, so its pain pattern is more localized to the inner hallux rather than the ball of the foot.

The pathology likely reflects chronic nerve compression and irritation rather than a single acute event. Over time, the nerve’s normal architecture is disrupted, and the patient experiences pain from both nerve inflammation and altered signal transmission. Because nerves are highly sensitive structures, even modest mechanical disturbance can produce significant symptoms.

Clinical Features

Patients typically describe pain along the medial aspect of the big toe, often with burning, tingling, numbness, or hypersensitivity to touch. The pain may worsen with shoes that press on the bunion region or with walking and prolonged standing. Some patients notice tenderness to palpation along the course of the nerve, while others report symptoms that are more intermittent and provoked by activity or certain footwear.

Unlike joint pain from hallux valgus itself, Joplin’s neuroma pain has a neuropathic character. It may feel sharp, electric, or radiating, and it can be out of proportion to visible structural findings. The symptoms can overlap with postoperative scar pain, localized neuritis, or other forefoot disorders, which is one reason diagnosis is often delayed.pure.

Diagnosis

Diagnosis is primarily clinical and rests on a careful history and examination. A clinician should ask about bunion deformity, prior bunion surgery, shoe-related aggravation, sensory symptoms, and any prior trauma to the forefoot. Focal tenderness over the medial plantar digital nerve to the hallux supports the diagnosis, especially when symptoms are reproducible with local pressure.

Imaging is often used to exclude other causes of great toe pain rather than to definitively confirm Joplin’s neuroma. Ultrasound or other imaging may help rule out alternative pathology, but the condition is usually recognized by its characteristic symptom pattern and location. As with other foot neuromas, the absence of a bony abnormality does not exclude a nerve problem, so clinical suspicion remains essential.

Conservative Treatment

Initial treatment is nonoperative. The first goal is to reduce mechanical irritation of the nerve. Wider footwear, softer uppers, avoidance of tight toe boxes, and offloading pads can make a major difference. Activity modification, icing, and anti-inflammatory medications may also provide relief, especially early in the course of the disorder.neurosurgery.

When symptoms persist, clinicians may consider medications aimed at neuropathic pain or corticosteroid injections in selected cases. The logic behind injection therapy is to reduce local inflammation and pressure around the irritated nerve. Although evidence is stronger for Morton’s neuroma than for Joplin’s neuroma specifically, the same principle is often applied in practice because the underlying pain mechanism is similar.neurosurgery.

Surgery

Surgery is generally reserved for patients who fail prolonged conservative treatment. In a small series, surgical resection of the affected medial digital nerve with implantation of the proximal stump into the arch of the foot produced good to excellent results in most patients, with about 80 percent reporting good-to-excellent pain relief. This suggests that carefully selected patients can benefit substantially when nonoperative care fails.pure.

The operative strategy aims to remove the painful segment, prevent recurrent neuroma formation, and reduce traction on the nerve stump. As with many peripheral nerve procedures, outcomes depend on the accuracy of diagnosis, the severity of preoperative nerve damage, and the presence of associated deformity such as bunion alignment problems.

Prognosis

The prognosis is usually favorable when the condition is recognized early and the mechanical cause is addressed. Many patients improve with footwear modification and offloading alone, especially if symptoms are mild or of short duration. Chronic cases, particularly those related to prior surgery or significant deformity, may require more aggressive treatment and can be harder to resolve completely.

Long-term outcomes depend on whether the nerve irritation can be stopped. If the bunion deformity or shoe pressure persists, the symptoms may recur even after temporary improvement. For that reason, treatment often needs to address both the nerve pain and the underlying biomechanical driver.

Joplin’s neuroma is a rare but important cause of medial big-toe pain. It is best understood as a painful fibrotic irritation of the medial plantar digital nerve, often linked to bunion deformity or bunion surgery. Recognition of its neuropathic symptom pattern is crucial because treatment is usually effective once the nerve is properly offloaded or, in refractory cases, surgically addressed.pure.

Jones Fracture in the Foot

A Jones fracture is a break in the fifth metatarsal, the long bone on the outer side of the foot that connects to the little toe. It is important because it occurs in a part of the bone with relatively limited blood supply, which makes healing slower and increases the risk of nonunion compared with many other foot fractures.

A Jones fracture usually follows a twisting injury, sudden impact, or repetitive stress to the outside of the foot. It is commonly seen in athletes, dancers, runners, and anyone who places repeated load through the lateral foot, especially during cutting, jumping, or pivoting movements.

Anatomy and Definition

The fifth metatarsal is divided into zones, and a true Jones fracture occurs in Zone 2, near the junction between the base and shaft of the bone. This is distinct from a tuberosity avulsion fracture at the base of the bone, which is sometimes called a pseudo-Jones fracture and generally heals more reliabl

The reason this fracture matters clinically is that the Zone 2 region lies in a vascular watershed area, where blood flow is comparatively poor. That reduced circulation helps explain why healing can be delayed and why some fractures fail to unite without more aggressive treatment.

Causes and Risk Factors

Jones fractures usually happen after the foot is forced into a twisted position while weight-bearing. Common mechanisms include sports injuries, sudden changes in direction, landing awkwardly from a jump, or stumbling on uneven ground.

Repetitive overuse can also contribute, especially in people who run or stand for long periods on hard surfaces. In some cases, foot alignment, high training loads, or a previous fracture may increase risk, although the exact contributor varies from person to person.

Symptoms

Typical symptoms include pain on the outer side of the foot, swelling, tenderness over the fifth metatarsal, and difficulty walking or bearing weight. Some people can still walk after the injury, but pain usually worsens with push-off, turning, or activity.

Bruising may appear, and the area is often painful to touch. Because symptoms can overlap with other lateral foot injuries, clinical assessment and imaging are usually needed to confirm the diagnosis.

Diagnosis

Diagnosis is usually made with a physical examination and an X-ray. The clinician looks for point tenderness over the fifth metatarsal and correlates that with imaging findings to identify the fracture location and pattern.

Correct classification is important because a Zone 2 Jones fracture has a different prognosis from other fifth metatarsal fractures. That distinction helps guide treatment and gives a better estimate of the expected recovery time.

Treatment

Treatment depends on the fracture pattern, degree of displacement, activity level, and patient goals. Initial care often includes rest, immobilization in a boot or cast, ice, elevation, pain control, and limiting weight-bearing to reduce stress across the fracture site.

Many Jones fractures, especially in active patients or athletes, are treated surgically because surgery can improve union rates and allow a more predictable recovery. Non-surgical treatment is possible in selected cases, but it often requires strict protection and close follow-up because delayed union and nonunion are more common than with many other fractures.

Recovery and Healing

Healing time varies, but many sources describe recovery as taking roughly three to four months, and sometimes longer if complications occur. Some patients may need six to eight weeks of immobilization first, followed by gradual progression back to weight-bearing and activity.

Return to sport or strenuous activity should be slow and guided by symptoms and clinical review. If the fracture does not heal as expected, or if pain persists, further treatment such as surgery or bone grafting may be needed.

Complications

The most important complications are delayed union, nonunion, and refracture. These problems are more likely in Jones fractures because of the limited blood supply in the fracture zone and the mechanical forces acting through the lateral foot during walking and sport.

Other complications may include prolonged pain, stiffness after immobilization, weakness of the surrounding muscles, and time away from work or sport. These issues highlight why early diagnosis and appropriate management are so important.

Clinical Importance

For clinicians, the Jones fracture is a classic injury because it sits at the intersection of biomechanics, vascular anatomy, and load management. It is not simply a “small foot fracture”; it is a fracture with meaningful implications for healing time, rehabilitation, and return to function.

For patients, the key message is that persistent pain on the outside of the foot after a twisting injury should not be ignored. Early assessment can prevent delayed treatment and reduce the chance of long-term problems.

A Jones fracture is a fracture of the fifth metatarsal in a high-risk healing zone of the foot. Because it has a greater chance of delayed healing than many other fractures, accurate diagnosis, proper immobilization, and careful follow-up are essential.

Heel fat pad atrophy is an increasingly recognised cause of plantar heel pain, especially in older or high‑impact populations, and is frequently misdiagnosed as plantar fasciopathy. It involves structural and functional failure of the calcaneal fat pad, resulting in reduced shock absorption, focal overloading of the calcaneus, and characteristic bruised, central heel pain with weightbearing.

Anatomy and biomechanics of the heel fat pad

The plantar calcaneal fat pad (corpus adiposum) is a specialised fibro‑adipose structure that overlies the inferior surface of the calcaneus. It is organised into elastic fat chambers separated by fibrous septa that anchor to the periosteum, designed to resist shear and dissipate vertical ground reaction forces during gait. In a healthy adult, heel pad thickness is typically around 1–2 cm, with ultrasound studies reporting unloaded thickness close to 18–20 mm and significant but controlled compressibility under load. During walking, the heel can be exposed to forces of approximately 110% of body weight, rising to around 200% during running, which the fat pad normally attenuates. This mechanical role explains why subtle structural change can produce disproportionate symptoms.

Pathophysiology and aetiology

Heel fat pad atrophy reflects thinning, fragmentation, or displacement of the corpus adiposum accompanied by loss of elasticity and hydration. Micromechanical failure of the fibrous septa is thought to reduce structural integrity, impairing shock absorption and allowing higher peak plantar pressures directly over the calcaneus. Over time, repetitive high‑impact loading, such as running or jumping, and prolonged standing on hard surfaces drive cumulative microtrauma and wear, particularly when combined with inadequate footwear or barefoot loading on rigid substrates.

Multiple intrinsic and extrinsic factors contribute. Ageing leads to reduced collagen elasticity, loss of soft‑tissue moisture, and thinning or displacement of the fat pad, making heel fat pad syndrome more prevalent in older adults. Biomechanical factors, including altered arch alignment, high arches, and abnormal gait patterns, shift load toward the posterior calcaneus and increase local stress. A history of corticosteroid injection into or near the heel has been associated with fat pad breakdown, presumably via catabolic effects on collagen and adipose tissue. Systemic factors such as obesity and certain medical conditions further compromise tissue integrity and may accelerate thinning. Less commonly, acute trauma or a single episode of excessive heel strike can precipitate symptomatic structural failure.

Clinical presentation and differential diagnosis

Clinically, patients typically describe a deep, dull, “bruised” pain centred under the heel that is provoked by weightbearing and worsens on hard surfaces or when walking barefoot. Standing or walking for prolonged periods aggravates symptoms, whereas non‑weightbearing usually provides rapid relief. On examination, there is focal tenderness beneath the posterior‑central calcaneus, often slightly lateral to the midline, corresponding to the main weightbearing point at heel strike. The pad may feel thinned or less resilient on palpation compared to the contralateral side, and compressive testing may reproduce pain.

Differentiating heel fat pad atrophy from plantar fasciopathy is clinically important, as management priorities differ. Plantar fasciitis usually presents with medial calcaneal and proximal fascial tenderness and pronounced “first‑step” pain after rest, whereas fat pad pain is more central/posterior, often maximal during prolonged standing or impact and particularly severe when barefoot on firm ground. Radiology and ultrasound can assist: imaging in heel fat pad syndrome may demonstrate reduced fat pad thickness, altered echotexture, septal defects, fibrosis, or oedema within or around the pad, whereas plantar fasciopathy shows fascial thickening and entheseal changes. A scoping review suggests heel fat pad syndrome may be the second most common cause of plantar heel pain, yet is frequently overlooked or conflated with plantar fasciopathy in the literature and in practice.

Investigations

Although heel fat pad atrophy is primarily a clinical diagnosis, imaging can provide objective corroboration and help exclude other pathology. Ultrasound offers a practical method to quantify heel pad thickness in unloaded and loaded states and to assess compressibility, with studies reporting abnormal thinning and altered compressibility indices in symptomatic patients. MRI can demonstrate changes such as focal atrophy, fibrosis, oedema, and septal defects, alongside assessment of surrounding soft tissues and bone marrow. Radiographs may be useful to assess calcaneal spurs or other bony pathology but are less informative regarding fat pad quality. Objective measurement can be valuable in tracking progression and response to interventions in both clinical and research settings.

Conservative management

Management is initially conservative and centres on reducing peak plantar pressures while optimising overall foot biomechanics. Activity modification is foundational: patients are advised to reduce or temporarily cease high‑impact activities such as distance running and court sports, substituting with lower‑impact exercise where possible. Footwear education is crucial, emphasising supportive shoes with firm heel counters, appropriate arch support, and adequate heel cushioning; walking barefoot or in thin‑soled footwear on hard surfaces is discouraged. External devices—including cushioned socks, silicone or gel heel cups, and custom or semi‑custom insoles—aim to increase cushioning and, importantly, to contain and centralise the fat pad under the calcaneus.

Clinical taping techniques can be used to “cup” and reposition the pad beneath the heel, providing symptomatic relief and serving as a predictor of orthotic response. Physiotherapy or podiatry‑led rehabilitation often includes strengthening of intrinsic and extrinsic foot and ankle musculature, improving load sharing and dynamic stability, as well as targeted mobilisation of the rearfoot, talocrural joint, and plantar fascia to restore normal motion patterns. Adjunctive measures, such as short periods of icing and judicious use of oral or topical non‑steroidal anti‑inflammatories, may assist during acute exacerbations, although they do not address the underlying structural deficit. Importantly, repeated corticosteroid injection into the heel should be avoided in this population because of its association with further fat pad compromise.

Emerging interventional approaches and evidence gaps

For patients who remain significantly symptomatic despite optimised conservative care, several interventional strategies have been explored, though the evidence base remains limited. These include injectable fillers and heel fat pad augmentation via autologous fat grafting, which aim to restore volume and shock‑absorbing capacity. Clinical trial protocols investigating autologous fat transfer suggest that improving plantar cushioning may reduce peak plantar pressures, potentially lowering the risk of ulceration in high‑risk groups such as individuals with diabetes and bony prominence. Early case series and small studies report imaging‑confirmed changes in fat pad morphology, including atrophy, fibrosis, and oedema, but there remains a “glaring absence” of robust controlled trials evaluating the long‑term efficacy and durability of commonly used conservative and surgical interventions.

Consequently, current best practice emphasises accurate diagnosis, comprehensive mechanical off‑loading, and optimisation of global foot function, while recognising that definitive regenerative solutions are still under investigation. From a clinical perspective, heel fat pad atrophy underscores the importance of viewing plantar heel pain as a heterogeneous symptom complex rather than a monolithic “plantar fasciitis” entity, demanding careful localisation of pain, biomechanical assessment, and tailored intervention.

Rigid carbon plates are a key non‑operative option for reducing first metatarsophalangeal joint (1st MTPJ) pain and improving function in patients with hallux rigidus by limiting painful dorsiflexion while preserving overall gait efficiency. Their use is supported by clinical studies on rigid and carbon‑based insoles, as well as growing clinical experience and commercial device design focused on targeted forefoot motion control.

Pathophysiology of hallux rigidus

Hallux rigidus is a degenerative arthropathy of the 1st MTPJ characterised by progressive cartilage loss, dorsal osteophyte formation, and reduced sagittal plane range of motion, particularly dorsiflexion. The loss of joint congruency and osteophyte impingement elevates joint reaction forces during propulsion, producing pain, stiffness, and altered push‑off mechanics.

As dorsiflexion becomes limited and painful, patients commonly compensate by externally rotating the foot, transferring load laterally to lesser metatarsal heads, or shortening step length, which can lead to secondary metatarsalgia, midfoot overload, and reduced walking speed. Conservative interventions therefore aim to reduce painful dorsiflexion moments at the 1st MTPJ while maintaining sufficient forefoot stability for efficient gait

Rationale for rigid carbon plates

Rigid orthoses have long been used to “splint” the first ray and limit 1st MTPJ motion as a primary strategy in conservative management of hallux rigidus. A systematic review of non‑operative care reports that footwear modifications and rigid custom insoles are effective in roughly half of patients, supporting their role as first‑line therapy.

Carbon fibre is particularly suited to this task because it offers very high stiffness at minimal thickness and weight, allowing substantial motion restriction with relatively low bulk. By stiffening the forefoot region of the shoe, carbon plates reduce bending at the ball of the foot so that the big toe joint does not need to dorsiflex as much during terminal stance, thereby decreasing joint loading and pain.

Design characteristics of carbon plates

Rigid carbon plates for hallux rigidus are usually thin (around 1.0–1.2 mm) and flat or slightly contoured, with minimal flex across the metatarsal heads. Their stiffness is achieved using high‑strength carbon (often combined with glass fibres) embedded in a polymer matrix, producing a durable, fatigue‑resistant structure that tolerates repetitive forefoot loading.

Two main geometries are commonly employed:

• Morton’s extension plates: extend under the hallux and first metatarsal, allowing more normal motion of the lateral metatarsophalangeal joints while specifically splinting the first ray.carboneaze+1
• Full‑width forefoot plates: span the entire forefoot, limiting motion at both the 1st MTPJ and lesser MTPJs and creating a more global rocker effect.

Choice of design is typically dictated by whether isolated first‑ray control is desired or whether broader forefoot immobilisation and rocker function are clinically advantageous.

Clinical evidence for carbon‑based insoles

Although many traditional devices used polypropylene or other rigid plastics, carbon fibre has increasingly been adopted as a base material for rigid 1st ray splinting orthoses. A randomized controlled trial comparing flexible carbon fibre insoles with a rigid Morton’s extension in patients with unilateral 1st MTPJ arthritis found that flexible carbon insoles produced significantly greater reductions in pain interference and pain intensity scores at 6 and 12 weeks, with higher comfort and better compliance.

Specifically, the flexible carbon group demonstrated larger median improvements in PROMIS pain interference and pain intensity scales, while the more rigid Morton’s extension did not achieve similar gains despite also restricting motion. The authors concluded that carbon‑based insoles which balance mechanical shielding with some preserved motion may provide superior symptom relief and patient adherence compared with very rigid orthoses.

Beyond this trial, a broader review of conservative hallux rigidus care notes that custom insoles fabricated from rigid materials, including carbon fibre, reduce symptoms in a substantial proportion of patients and carry a moderate level of evidence within an evidence‑based framework. Emerging work in related forefoot and midfoot pathologies also suggests that full‑length carbon insoles can reduce forefoot loading and alter muscle activation patterns in ways that may support pain reduction and gait efficiency.

Mechanisms of symptom relief

Rigid carbon plates treat hallux rigidus primarily through mechanical modification of the 1st MTPJ environment:

• Motion restriction: By limiting dorsiflexion at the 1st MTPJ, plates decrease peak articular cartilage stress and dorsal osteophyte impingement during propulsion.
• Load redistribution: The stiffened forefoot encourages a more rocker‑like gait, shifting load proximally and to adjacent structures rather than concentrating it at the arthritic joint.
• Capsular protection: In conditions such as turf toe and big‑toe arthritis, carbon plates protect the joint capsule from excessive dorsiflexion and repetitive microtrauma.

These mechanical effects collectively reduce pain, dampen inflammatory flares, and may slow progression of degenerative change by limiting repeated high‑stress motion at the affected joint.

Integration with footwear and orthoses

Successful use of rigid carbon plates depends heavily on shoe compatibility and integration with existing orthotic therapy. Many clinicians either place the plate directly under the insole in a suitable shoe, or incorporate it into a custom device to avoid excess bulk and maintain foot position control. Full‑length plates often work best in footwear with adequate depth and a relatively stiff outsole, further enhancing the rocker function created by the plate.

Layering a carbon plate beneath a functional orthotic can be particularly useful in hallux rigidus, with the plate restricting painful toe motion while the orthosis addresses rearfoot and midfoot mechanics and redistributes plantar pressures. However, excessive stack height from combining OTC inserts with separate plates can compromise fit and comfort, so careful device selection and shoe testing are important.

Advantages and limitations

Rigid carbon plates offer several practical advantages in managing hallux rigidus:

• High stiffness with low profile and weight, improving shoe fit compared with many traditional rigid insoles.
• Reversible, non‑invasive intervention compatible with other conservative measures such as NSAIDs, intra‑articular injections, and physiotherapy.
• Versatility in design (Morton’s extension vs full‑width) to tailor motion restriction to the individual’s pathology and activity demands.

Conversely, limitations include potential discomfort from excessive rigidity, difficulty fitting plates into fashion or low‑volume footwear, and patient reluctance to accept changes in shoe feel or forefoot rocker mechanics. Over‑restriction of forefoot motion may transfer stress to proximal joints or lesser MTPJs, and plates may not adequately control pain in advanced cases where surgical options such as cheilectomy, arthrodesis, or arthroplasty are more appropriate.

Place in overall management

Within the broader conservative algorithm for hallux rigidus—alongside pharmacologic therapy, intra‑articular injections, activity modification, and footwear changes—rigid carbon plates occupy a central role as a mechanical pain‑relief strategy that can delay or obviate surgery for many patients. Evidence indicates that about half of patients achieve meaningful symptom control with such conservative measures, justifying early and systematic use of these devices.

Contemporary research comparing rigid Morton’s extensions with flexible carbon fibre insoles suggests that optimal plate design for hallux rigidus may require a nuanced balance between sufficient rigidity to shield the joint and enough flexibility to preserve comfort and normal mechanics. For clinicians and patients, rigid and semi‑rigid carbon plates therefore represent a valuable, adaptable tool in the non‑operative management of hallux rigidus, particularly when carefully matched to footwear, orthotic strategy, and the individual’s functional goals.

Hallux rigidus is a degenerative arthritis of the first metatarsophalangeal (MTP) joint that leads to pain and progressive loss of dorsiflexion of the hallux, ultimately impairing gait and limiting activities that require push‑off. Treatment revolves around symptom relief, preservation of joint motion where possible, and restoration of function, using a stepwise approach from conservative care to surgery depending on disease severity, patient demands, and radiographic changes.

Principles and goals of treatment

The primary goals of treating hallux rigidus are to relieve pain, maintain or improve range of motion, and allow patients to walk and perform daily activities without significant limitation. Management must be individualized by considering the clinical stage (e.g. mild, moderate, or advanced arthritis), alignment of the first ray, patient age, activity level, and expectations regarding joint motion. In early stages, joint‑preserving strategies are typically preferred, whereas in end‑stage disease, procedures that sacrifice motion in exchange for reliable pain relief, such as arthrodesis, are often indicated.

Conservative management

Non‑operative treatment is recommended as first‑line management and can provide meaningful relief in approximately half of patients, particularly those with mild to moderate disease. Pharmacological measures include non‑steroidal anti‑inflammatory drugs (NSAIDs) to reduce synovitis and pain, although these rarely provide complete or lasting symptom control when used alone. Intra‑articular corticosteroid injections can produce short‑term pain relief—often on the order of weeks to a few months—with diminishing returns in more advanced grades, and intra‑articular hyaluronic acid has demonstrated a reduction in pain and improved function several months after injection in some series.

Footwear modification and orthoses represent key elements of conservative care. Stiff‑soled shoes, rocker‑bottom soles, and shoes with a higher toe box limit painful dorsiflexion at the first MTP joint and reduce pressure over dorsal osteophytes. Custom insoles or orthotics can offload the first MTP joint, support the medial longitudinal arch, and sometimes incorporate a Morton’s extension or carbon fiber plate to further reduce joint motion during push‑off. Collectively, footwear changes, insoles, and injections are among the most effective conservative strategies according to evidence‑based reviews, with moderate‑grade recommendations.

Physical and manual therapy approaches, while supported by relatively low‑level evidence, aim to optimize joint mechanics and muscular support. Interventions may include great toe mobilization, long‑axis traction of the MTP joint, mobilization of the sesamoids, stretching of capsular and tendon structures, and strengthening of the flexor hallucis longus and intrinsic foot muscles to improve the pulley mechanism and dynamic stabilization. Dynamic splinting to encourage first MTP extension has been reported to significantly increase active range of motion post‑operatively and could theoretically reduce progression from hallux limitus to rigidus, though robust randomized data are limited. Overall, conservative programs are best viewed as comprehensive packages that combine medication, injections, footwear modification, and targeted rehabilitation rather than single isolated modalities.

Joint‑sparing surgical options

When conservative measures fail, and especially in grades I–III disease where some dorsiflexion remains and joint surfaces are not completely destroyed, joint‑sparing operations are considered. The most established of these is cheilectomy, which consists of resecting dorsal osteophytes and a portion of the dorsal metatarsal head to improve dorsiflexion and reduce impingement. For early stages, cheilectomy alone has demonstrated excellent pain relief and functional outcomes, and even in some grade III cases, series have shown substantial improvement in visual analogue scale pain scores with low revision rates.

Cheilectomy can be combined with proximal phalanx osteotomy, such as a Moberg dorsal closing‑wedge osteotomy, to further increase dorsiflexion by shifting the arc of motion. In a cohort of high‑grade hallux rigidus, the combination of cheilectomy and Moberg osteotomy led to improved dorsiflexion, high patient satisfaction, and a low conversion rate to arthrodesis at mid‑term follow‑up, suggesting this is a reasonable option for active patients with residual motion pre‑operatively. Arthroscopic techniques allow debridement and dorsal cheilectomy through small portals and have been described mainly for grade I–II disease, offering potential benefits in terms of soft‑tissue preservation and recovery, though long‑term outcome data remain limited.

Interpositional arthroplasty is another joint‑sparing strategy mainly reserved for moderate to severe hallux rigidus in patients who strongly wish to preserve motion. Classic procedures such as Keller resection arthroplasty remove a portion of the base of the proximal phalanx, often combined with soft‑tissue interposition, but excessive resection can lead to toe weakening, shortening, and transfer metatarsalgia. Modern interpositional techniques may use capsular flaps, tendon graft, or synthetic materials as spacers to maintain joint space and allow painless motion, but outcomes can be more variable and less predictable than arthrodesis. Synthetic cartilage implants, such as polyvinyl alcohol hydrogel spacers, have shown short‑term results comparable to arthrodesis in terms of pain and function at around two years, with the advantage of preserving motion and a reported failure rate near 10%, though longer‑term durability is still under investigation.

Joint‑sacrificing procedures

In end‑stage hallux rigidus with severe cartilage loss, large osteophytes, and minimal remaining motion, joint‑sacrificing procedures are most commonly used. Arthrodesis of the first MTP joint is widely regarded as the gold standard for advanced disease because it reliably eliminates arthritic pain and provides a stable, plantigrade toe for push‑off. The procedure involves removal of the residual cartilage, preparation of subchondral bone, and fusion of the proximal phalanx to the metatarsal using screws and/or plates, with union rates typically high and long‑term satisfaction favorable. The trade‑off is permanent loss of first MTP motion, which can limit certain activities (e.g. kneeling, sprinting, high‑heeled shoes), but many patients adapt well with proper alignment of the fusion.

Implant arthroplasty, using metallic or silastic prostheses, aims to maintain joint motion while resurfacing arthritic surfaces. However, concerns exist about implant loosening, subsidence, and revision complexity over time, and evidence has not consistently shown superiority to arthrodesis in terms of pain relief and durability. For low‑demand or elderly patients reluctant to accept a fusion, implant arthroplasty or interpositional arthroplasty may still be considered, but careful counselling regarding risks, potential for failure, and need for eventual conversion to arthrodesis is essential.

Treatment selection and future directions

Choosing among the available treatments requires a structured assessment that integrates clinical staging, radiographic findings, and patient‑specific goals. In practice, early disease is often managed with a combination of footwear modification, orthoses, NSAIDs, injections, and possibly manual therapy, progressing to cheilectomy (with or without proximal phalanx osteotomy) if symptoms persist. For intermediate disease in active individuals with some preserved motion, extended cheilectomy, Moberg osteotomy, or interpositional/synthetic cartilage arthroplasty may be appropriate, while advanced cases with near‑complete cartilage loss are usually best served by first MTP arthrodesis.

Emerging options such as biologic injections (platelet‑rich plasma, bone marrow aspirate) and novel implant materials are being explored, but current evidence is insufficient to draw firm conclusions about their long‑term efficacy in hallux rigidus. High‑quality randomized controlled trials are still needed, particularly in the domain of physiotherapy and manual therapy, to clarify which conservative protocols offer the greatest benefit. For now, a graded, evidence‑informed approach that starts with conservative measures and progresses to well‑selected surgical procedures offers the best chance of restoring pain‑free function for patients with this common and disabling condition.

Hammer toes are a common forefoot deformity in which one or more lesser toes bend at the middle joint, producing pain, corns, and difficulty with footwear. Treatment focuses first on relieving symptoms and preventing progression with conservative measures, and only then on corrective surgery if deformity and pain persist.

Goals of treatment

Management of hammer toes aims to:

• Reduce pain and pressure from shoes and ground contact.
• Correct or control the deforming forces (muscle imbalance, tight tendons, poor footwear).
• Prevent secondary problems such as corns, calluses, ulceration, and difficulty walking.
• Straighten the toe and restore function when possible, particularly with surgery in rigid cases.

The choice between non‑surgical and surgical treatment depends mainly on whether the toe is still flexible, the intensity of pain, and the impact on daily activities.

Conservative (non‑surgical) treatment

Non‑surgical treatment is the first line for flexible or mildly symptomatic hammer toes and often gives substantial relief.

1. Footwear modification
   • Patients are advised to avoid tight, narrow, and high‑heeled shoes that crowd the toes and increase pressure on the bent joint.
   • Recommended shoes have a wide, deep toe box and low heels, and are about half a size longer than the longest toe so that there is space for the deformity and any protective padding.
2. Padding, cushioning, and taping
   • Soft pads, sleeves, or cushioning over the prominent joint redistribute pressure and reduce friction, which helps relieve pain and prevents corns and calluses.
   • Taping or splinting the toe can hold it in a straighter position, temporarily correcting muscle imbalance and lessening irritation in shoes.
3. Orthotic devices and shoe inserts
   • Prefabricated or custom orthotic insoles support the arch and alter load distribution, reducing stress on the metatarsal region and toe joints
   • By improving foot biomechanics, orthotics may slow progression of the deformity, especially when hammer toe is associated with flat feet or other structural problems.
4. Exercises and stretching
   • Toe‑strengthening and stretching exercises are often prescribed when the toe is still flexible, such as picking up marbles with the toes or scrunching a towel, to improve intrinsic muscle balance.
   • Gentle manual stretches of the affected toe and calf‑muscle stretching can help reduce tendon tightness and maintain joint motion.
5. Medications and injections
   • Oral non‑steroidal anti‑inflammatory drugs (NSAIDs) can reduce pain and inflammation around the affected joints in symptomatic periods.
6. Skin and nail care
   • Regular debridement of corns and calluses by a podiatrist, combined with ongoing padding and proper footwear, reduces pain and risk of skin breakdown.
   • Patients at higher risk, such as those with diabetes or poor circulation, need careful monitoring to prevent ulcers over the prominent joints

Conservative care of hammer toes does not typically “reverse” an established deformity, but it often controls symptoms sufficiently that many patients avoid or delay surgery.

Indications for surgery

Surgery is considered when non‑surgical measures fail and the patient continues to have significant pain, difficulty wearing shoes, or functional limitations. Rigid toes that cannot be passively straightened, recurrent corns despite adequate footwear, and deformities causing ulceration are common indications.

Before surgery, clinicians assess:

• Flexibility of the toe (flexible vs fixed deformity).
• Condition of adjacent joints and overall foot alignment.
• Patient health, activity level, and expectations for recovery.

Most procedures are performed as day surgery with local or regional anesthesia.

Surgical techniques

The specific operation is tailored to the severity and rigidity of the toe deformity.

1. Soft‑tissue procedures (flexible hammer toes)
   • In flexible deformities, the main problem is often tendon and ligament imbalance, so operations aim to lengthen or transfer tendons without removing much bone.
   • Tendon lengthening reduces the excessive pull that keeps the toe bent, while tendon transfer (typically from the underside of the toe to the top) repositions the tendon so that it helps straighten and hold the toe down.
2. Bone procedures and joint resection (rigid hammer toes)
   • When the joint is stiff and fixed, surgeons may remove a small piece of bone from the proximal phalanx or the joint surfaces (arthroplasty) to allow the toe to straighten.nyp+3
   • In more severe deformities, the joint may be fused (arthrodesis) using pins, screws, or other implants, so the bone ends heal together into a single, straight segment that eliminates the painful motion.
3. Fixation and minimally invasive methods
   • Temporary pins are sometimes placed across the joint to maintain alignment while soft tissues and bone heal; they are usually removed after a few weeks once stability is achieved.
   • Some centres use key‑hole or minimally invasive techniques with small skin portals to cut bone and release soft tissues, aiming for less postoperative pain and swelling and quicker recovery.

Overall, the goal of surgery is to correct the deformity sufficiently to relieve pain and allow comfortable shoe wear, rather than to create a perfectly “normal‑looking” toe.mayoclinic+2

Postoperative care and outcomes

After hammer toe surgery, patients typically go home the same day in a protective shoe, with instructions to elevate the foot and limit weight‑bearing initially. Stitches and any external pins are removed after a short healing period, and patients gradually progress to normal footwear as swelling and tenderness settle, often over 4–6 weeks, with fuller return to all footwear and activities by around three months depending on the procedure.

Pain usually decreases significantly once healing has occurred, and most patients report improved shoe comfort and walking ability. However, there are recognised risks, including infection, stiffness, residual deformity, recurrence, or dissatisfaction with toe appearance, so careful patient selection and realistic preoperative counselling are essential. Even after surgery, ongoing attention to shoe choice and, where appropriate, orthotics and exercises remains important to protect the operated toe and prevent problems in adjacent toes.